Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data

Identifieur interne : 002836 ( Main/Corpus ); précédent : 002835; suivant : 002837

Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data

Auteurs : Naheed L. Khan ; Shushant Jain ; John M. Lynch ; Nicola Pavese ; Patrick Abou-Sleiman ; Janice L. Holton ; Daniel G. Healy ; William P. Gilks ; Mary G. Sweeney ; Milan Ganguly ; Vaneesha Gibbons ; Sonia Gandhi ; Jenny Vaughan ; Louise H. Eunson ; Regina Katzenschlager ; Juliet Gayton ; Graham Lennox ; Tamas Revesz ; David Nicholl ; Kailash P. Bhatia ; Niall Quinn ; David Brooks ; Andrew J. Lees ; Mary B. Davis ; Paola Piccini ; Andrew B. Singleton ; Nicholas W. Wood

Source :

RBID : ISTEX:F12E94D16215631DFA9811475DAA34935074D886

English descriptors

Abstract

We have established that the frequency of LRRK2 mutations in a series of 118 cases of familial Parkinson's disease is 5.1%. In the largest family with autosomal dominant, late-onset Parkinson's disease where affected subjects share a Y1699C missense mutation we provide a detailed clinical, pathological and imaging report. The phenotype in this large British kindred included asymmetrical, levodopa-responsive parkinsonism where unilateral leg tremor at onset and foot dystonia were prominent features. There was no significant abnormality of cognition but there was prominent behavioural disorder. We observed a lower age of onset in successive generations. Histopathology in one patient showed substantia nigra cell loss and Lewy body formation, with small numbers of cortical Lewy bodies. 18F-dopa positron emission tomography (PET) in another patient showed a pattern of nigrostriatal dysfunction typical of idiopathic Parkinson's disease. 18F-dopa-PET scans in unaffected family members prior to identifying the disease locus did not detect subclinical nigrostriatal dysfunction. Olfaction was assessed in affected subjects and Lewy bodies were identified in the olfactory bulb as well as cortex and brainstem of one deceased patient. In order to assess the role of mutations in this gene in other familial cases we undertook a mutation screen of all 51 exons of LRRK2 in 117 other smaller British kindreds with familial Parkinson's disease. The commonest mutation was G2019S and we also identified two novel mutations, R1941H and T2356I, in the coding sequence. These data suggest that parkinsonism caused by mutations in LRRK2 is likely to represent the commonest locus for autosomal dominant Parkinson's disease with a phenotype, pathology and in vivo imaging similar to idiopathic, late-onset Parkinson's disease.

Url:
DOI: 10.1093/brain/awh667

Links to Exploration step

ISTEX:F12E94D16215631DFA9811475DAA34935074D886

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data</title>
<author>
<name sortKey="Khan, Naheed L" sort="Khan, Naheed L" uniqKey="Khan N" first="Naheed L." last="Khan">Naheed L. Khan</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Jain, Shushant" sort="Jain, Shushant" uniqKey="Jain S" first="Shushant" last="Jain">Shushant Jain</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lynch, John M" sort="Lynch, John M" uniqKey="Lynch J" first="John M." last="Lynch">John M. Lynch</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pavese, Nicola" sort="Pavese, Nicola" uniqKey="Pavese N" first="Nicola" last="Pavese">Nicola Pavese</name>
<affiliation>
<mods:affiliation>MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Abou Sleiman, Patrick" sort="Abou Sleiman, Patrick" uniqKey="Abou Sleiman P" first="Patrick" last="Abou-Sleiman">Patrick Abou-Sleiman</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Holton, Janice L" sort="Holton, Janice L" uniqKey="Holton J" first="Janice L." last="Holton">Janice L. Holton</name>
<affiliation>
<mods:affiliation>Queen Square Brain Bank, Institute of Neurology,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Healy, Daniel G" sort="Healy, Daniel G" uniqKey="Healy D" first="Daniel G." last="Healy">Daniel G. Healy</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gilks, William P" sort="Gilks, William P" uniqKey="Gilks W" first="William P." last="Gilks">William P. Gilks</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sweeney, Mary G" sort="Sweeney, Mary G" uniqKey="Sweeney M" first="Mary G." last="Sweeney">Mary G. Sweeney</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ganguly, Milan" sort="Ganguly, Milan" uniqKey="Ganguly M" first="Milan" last="Ganguly">Milan Ganguly</name>
<affiliation>
<mods:affiliation>Queen Square Brain Bank, Institute of Neurology,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gibbons, Vaneesha" sort="Gibbons, Vaneesha" uniqKey="Gibbons V" first="Vaneesha" last="Gibbons">Vaneesha Gibbons</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gandhi, Sonia" sort="Gandhi, Sonia" uniqKey="Gandhi S" first="Sonia" last="Gandhi">Sonia Gandhi</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Vaughan, Jenny" sort="Vaughan, Jenny" uniqKey="Vaughan J" first="Jenny" last="Vaughan">Jenny Vaughan</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Eunson, Louise H" sort="Eunson, Louise H" uniqKey="Eunson L" first="Louise H." last="Eunson">Louise H. Eunson</name>
<affiliation>
<mods:affiliation>Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Katzenschlager, Regina" sort="Katzenschlager, Regina" uniqKey="Katzenschlager R" first="Regina" last="Katzenschlager">Regina Katzenschlager</name>
<affiliation>
<mods:affiliation>Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gayton, Juliet" sort="Gayton, Juliet" uniqKey="Gayton J" first="Juliet" last="Gayton">Juliet Gayton</name>
<affiliation>
<mods:affiliation>Exeter University, Exeter,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lennox, Graham" sort="Lennox, Graham" uniqKey="Lennox G" first="Graham" last="Lennox">Graham Lennox</name>
<affiliation>
<mods:affiliation>Department of Neurology, Addenbrooke's Hospital, Hills Road, Cambridge,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Revesz, Tamas" sort="Revesz, Tamas" uniqKey="Revesz T" first="Tamas" last="Revesz">Tamas Revesz</name>
<affiliation>
<mods:affiliation>Queen Square Brain Bank, Institute of Neurology,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Nicholl, David" sort="Nicholl, David" uniqKey="Nicholl D" first="David" last="Nicholl">David Nicholl</name>
<affiliation>
<mods:affiliation>Department of Neurology, Queen Elizabeth Hospital, Birmingham, UK and</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name>
<affiliation>
<mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Quinn, Niall" sort="Quinn, Niall" uniqKey="Quinn N" first="Niall" last="Quinn">Niall Quinn</name>
<affiliation>
<mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brooks, David" sort="Brooks, David" uniqKey="Brooks D" first="David" last="Brooks">David Brooks</name>
<affiliation>
<mods:affiliation>MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew J. Lees</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Davis, Mary B" sort="Davis, Mary B" uniqKey="Davis M" first="Mary B." last="Davis">Mary B. Davis</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Piccini, Paola" sort="Piccini, Paola" uniqKey="Piccini P" first="Paola" last="Piccini">Paola Piccini</name>
<affiliation>
<mods:affiliation>MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Singleton, Andrew B" sort="Singleton, Andrew B" uniqKey="Singleton A" first="Andrew B." last="Singleton">Andrew B. Singleton</name>
<affiliation>
<mods:affiliation>Laboratory of Neurogenetics, National Institute of Aging, National Institutes of Health, Bethesda, MD, USA</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wood, Nicholas W" sort="Wood, Nicholas W" uniqKey="Wood N" first="Nicholas W." last="Wood">Nicholas W. Wood</name>
<affiliation>
<mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F12E94D16215631DFA9811475DAA34935074D886</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1093/brain/awh667</idno>
<idno type="url">https://api.istex.fr/document/F12E94D16215631DFA9811475DAA34935074D886/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">002836</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data</title>
<author>
<name sortKey="Khan, Naheed L" sort="Khan, Naheed L" uniqKey="Khan N" first="Naheed L." last="Khan">Naheed L. Khan</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Jain, Shushant" sort="Jain, Shushant" uniqKey="Jain S" first="Shushant" last="Jain">Shushant Jain</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lynch, John M" sort="Lynch, John M" uniqKey="Lynch J" first="John M." last="Lynch">John M. Lynch</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pavese, Nicola" sort="Pavese, Nicola" uniqKey="Pavese N" first="Nicola" last="Pavese">Nicola Pavese</name>
<affiliation>
<mods:affiliation>MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Abou Sleiman, Patrick" sort="Abou Sleiman, Patrick" uniqKey="Abou Sleiman P" first="Patrick" last="Abou-Sleiman">Patrick Abou-Sleiman</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Holton, Janice L" sort="Holton, Janice L" uniqKey="Holton J" first="Janice L." last="Holton">Janice L. Holton</name>
<affiliation>
<mods:affiliation>Queen Square Brain Bank, Institute of Neurology,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Healy, Daniel G" sort="Healy, Daniel G" uniqKey="Healy D" first="Daniel G." last="Healy">Daniel G. Healy</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gilks, William P" sort="Gilks, William P" uniqKey="Gilks W" first="William P." last="Gilks">William P. Gilks</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sweeney, Mary G" sort="Sweeney, Mary G" uniqKey="Sweeney M" first="Mary G." last="Sweeney">Mary G. Sweeney</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ganguly, Milan" sort="Ganguly, Milan" uniqKey="Ganguly M" first="Milan" last="Ganguly">Milan Ganguly</name>
<affiliation>
<mods:affiliation>Queen Square Brain Bank, Institute of Neurology,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gibbons, Vaneesha" sort="Gibbons, Vaneesha" uniqKey="Gibbons V" first="Vaneesha" last="Gibbons">Vaneesha Gibbons</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gandhi, Sonia" sort="Gandhi, Sonia" uniqKey="Gandhi S" first="Sonia" last="Gandhi">Sonia Gandhi</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Vaughan, Jenny" sort="Vaughan, Jenny" uniqKey="Vaughan J" first="Jenny" last="Vaughan">Jenny Vaughan</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Eunson, Louise H" sort="Eunson, Louise H" uniqKey="Eunson L" first="Louise H." last="Eunson">Louise H. Eunson</name>
<affiliation>
<mods:affiliation>Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Katzenschlager, Regina" sort="Katzenschlager, Regina" uniqKey="Katzenschlager R" first="Regina" last="Katzenschlager">Regina Katzenschlager</name>
<affiliation>
<mods:affiliation>Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gayton, Juliet" sort="Gayton, Juliet" uniqKey="Gayton J" first="Juliet" last="Gayton">Juliet Gayton</name>
<affiliation>
<mods:affiliation>Exeter University, Exeter,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lennox, Graham" sort="Lennox, Graham" uniqKey="Lennox G" first="Graham" last="Lennox">Graham Lennox</name>
<affiliation>
<mods:affiliation>Department of Neurology, Addenbrooke's Hospital, Hills Road, Cambridge,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Revesz, Tamas" sort="Revesz, Tamas" uniqKey="Revesz T" first="Tamas" last="Revesz">Tamas Revesz</name>
<affiliation>
<mods:affiliation>Queen Square Brain Bank, Institute of Neurology,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Nicholl, David" sort="Nicholl, David" uniqKey="Nicholl D" first="David" last="Nicholl">David Nicholl</name>
<affiliation>
<mods:affiliation>Department of Neurology, Queen Elizabeth Hospital, Birmingham, UK and</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name>
<affiliation>
<mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Quinn, Niall" sort="Quinn, Niall" uniqKey="Quinn N" first="Niall" last="Quinn">Niall Quinn</name>
<affiliation>
<mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brooks, David" sort="Brooks, David" uniqKey="Brooks D" first="David" last="Brooks">David Brooks</name>
<affiliation>
<mods:affiliation>MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew J. Lees</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Davis, Mary B" sort="Davis, Mary B" uniqKey="Davis M" first="Mary B." last="Davis">Mary B. Davis</name>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Piccini, Paola" sort="Piccini, Paola" uniqKey="Piccini P" first="Paola" last="Piccini">Paola Piccini</name>
<affiliation>
<mods:affiliation>MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Singleton, Andrew B" sort="Singleton, Andrew B" uniqKey="Singleton A" first="Andrew B." last="Singleton">Andrew B. Singleton</name>
<affiliation>
<mods:affiliation>Laboratory of Neurogenetics, National Institute of Aging, National Institutes of Health, Bethesda, MD, USA</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wood, Nicholas W" sort="Wood, Nicholas W" uniqKey="Wood N" first="Nicholas W." last="Wood">Nicholas W. Wood</name>
<affiliation>
<mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders,</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Molecular Neuroscience,</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Brain</title>
<title level="j" type="abbrev">Brain</title>
<idno type="ISSN">0006-8950</idno>
<idno type="eISSN">1460-2156</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date type="published" when="2005-12">2005-12</date>
<biblScope unit="volume">128</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="2786">2786</biblScope>
<biblScope unit="page" to="2796">2796</biblScope>
</imprint>
<idno type="ISSN">0006-8950</idno>
</series>
<idno type="istex">F12E94D16215631DFA9811475DAA34935074D886</idno>
<idno type="DOI">10.1093/brain/awh667</idno>
<idno type="local">awh667</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0006-8950</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>ARSAC = Administration of Radioactive Substances Advisory Committee</term>
<term>F-dopa PET = 18F-dopa positron emission tomography</term>
<term>LOD = logarithm of the odds</term>
<term>LRRK2</term>
<term>LRRK2 = leucine-rich, repeat kinase 2</term>
<term>Lewy bodies</term>
<term>NFTs = neurofibrillary tangles</term>
<term>NHNN = National Hospital for Neurology and Neurosurgery</term>
<term>UPSIT = University of Pennsylvania Smell Identification Test</term>
<term>cM = centimorgan</term>
<term>dardarin</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We have established that the frequency of LRRK2 mutations in a series of 118 cases of familial Parkinson's disease is 5.1%. In the largest family with autosomal dominant, late-onset Parkinson's disease where affected subjects share a Y1699C missense mutation we provide a detailed clinical, pathological and imaging report. The phenotype in this large British kindred included asymmetrical, levodopa-responsive parkinsonism where unilateral leg tremor at onset and foot dystonia were prominent features. There was no significant abnormality of cognition but there was prominent behavioural disorder. We observed a lower age of onset in successive generations. Histopathology in one patient showed substantia nigra cell loss and Lewy body formation, with small numbers of cortical Lewy bodies. 18F-dopa positron emission tomography (PET) in another patient showed a pattern of nigrostriatal dysfunction typical of idiopathic Parkinson's disease. 18F-dopa-PET scans in unaffected family members prior to identifying the disease locus did not detect subclinical nigrostriatal dysfunction. Olfaction was assessed in affected subjects and Lewy bodies were identified in the olfactory bulb as well as cortex and brainstem of one deceased patient. In order to assess the role of mutations in this gene in other familial cases we undertook a mutation screen of all 51 exons of LRRK2 in 117 other smaller British kindreds with familial Parkinson's disease. The commonest mutation was G2019S and we also identified two novel mutations, R1941H and T2356I, in the coding sequence. These data suggest that parkinsonism caused by mutations in LRRK2 is likely to represent the commonest locus for autosomal dominant Parkinson's disease with a phenotype, pathology and in vivo imaging similar to idiopathic, late-onset Parkinson's disease.</div>
</front>
</TEI>
<istex>
<corpusName>oup</corpusName>
<author>
<json:item>
<name>Naheed L. Khan</name>
<affiliations>
<json:string>Department of Molecular Neuroscience,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Shushant Jain</name>
<affiliations>
<json:string>Department of Molecular Neuroscience,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>John M. Lynch</name>
<affiliations>
<json:string>Department of Molecular Neuroscience,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Nicola Pavese</name>
<affiliations>
<json:string>MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Patrick Abou-Sleiman</name>
<affiliations>
<json:string>Department of Molecular Neuroscience,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Janice L. Holton</name>
<affiliations>
<json:string>Queen Square Brain Bank, Institute of Neurology,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Daniel G. Healy</name>
<affiliations>
<json:string>Department of Molecular Neuroscience,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>William P. Gilks</name>
<affiliations>
<json:string>Department of Molecular Neuroscience,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Mary G. Sweeney</name>
<affiliations>
<json:string>Department of Molecular Neuroscience,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Milan Ganguly</name>
<affiliations>
<json:string>Queen Square Brain Bank, Institute of Neurology,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Vaneesha Gibbons</name>
<affiliations>
<json:string>Department of Molecular Neuroscience,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Sonia Gandhi</name>
<affiliations>
<json:string>Department of Molecular Neuroscience,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Jenny Vaughan</name>
<affiliations>
<json:string>Department of Molecular Neuroscience,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Louise H. Eunson</name>
<affiliations>
<json:string>Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Regina Katzenschlager</name>
<affiliations>
<json:string>Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Juliet Gayton</name>
<affiliations>
<json:string>Exeter University, Exeter,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Graham Lennox</name>
<affiliations>
<json:string>Department of Neurology, Addenbrooke's Hospital, Hills Road, Cambridge,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Tamas Revesz</name>
<affiliations>
<json:string>Queen Square Brain Bank, Institute of Neurology,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>David Nicholl</name>
<affiliations>
<json:string>Department of Neurology, Queen Elizabeth Hospital, Birmingham, UK and</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Kailash P. Bhatia</name>
<affiliations>
<json:string>Sobell Department of Motor Neuroscience and Movement Disorders,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Niall Quinn</name>
<affiliations>
<json:string>Sobell Department of Motor Neuroscience and Movement Disorders,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>David Brooks</name>
<affiliations>
<json:string>MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Andrew J. Lees</name>
<affiliations>
<json:string>Department of Molecular Neuroscience,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Mary B. Davis</name>
<affiliations>
<json:string>Department of Molecular Neuroscience,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Paola Piccini</name>
<affiliations>
<json:string>MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Andrew B. Singleton</name>
<affiliations>
<json:string>Laboratory of Neurogenetics, National Institute of Aging, National Institutes of Health, Bethesda, MD, USA</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
<json:item>
<name>Nicholas W. Wood</name>
<affiliations>
<json:string>Sobell Department of Motor Neuroscience and Movement Disorders,</json:string>
<json:string>Department of Molecular Neuroscience,</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Original Articles</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>LRRK2</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dardarin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Lewy bodies</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>ARSAC = Administration of Radioactive Substances Advisory Committee</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>cM = centimorgan</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>F-dopa PET = 18F-dopa positron emission tomography</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>LRRK2 = leucine-rich, repeat kinase 2</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>LOD = logarithm of the odds</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>NHNN = National Hospital for Neurology and Neurosurgery</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>NFTs = neurofibrillary tangles</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>UPSIT = University of Pennsylvania Smell Identification Test</value>
</json:item>
</subject>
<language>
<json:string>eng</json:string>
</language>
<abstract>We have established that the frequency of LRRK2 mutations in a series of 118 cases of familial Parkinson's disease is 5.1%. In the largest family with autosomal dominant, late-onset Parkinson's disease where affected subjects share a Y1699C missense mutation we provide a detailed clinical, pathological and imaging report. The phenotype in this large British kindred included asymmetrical, levodopa-responsive parkinsonism where unilateral leg tremor at onset and foot dystonia were prominent features. There was no significant abnormality of cognition but there was prominent behavioural disorder. We observed a lower age of onset in successive generations. Histopathology in one patient showed substantia nigra cell loss and Lewy body formation, with small numbers of cortical Lewy bodies. 18F-dopa positron emission tomography (PET) in another patient showed a pattern of nigrostriatal dysfunction typical of idiopathic Parkinson's disease. 18F-dopa-PET scans in unaffected family members prior to identifying the disease locus did not detect subclinical nigrostriatal dysfunction. Olfaction was assessed in affected subjects and Lewy bodies were identified in the olfactory bulb as well as cortex and brainstem of one deceased patient. In order to assess the role of mutations in this gene in other familial cases we undertook a mutation screen of all 51 exons of LRRK2 in 117 other smaller British kindreds with familial Parkinson's disease. The commonest mutation was G2019S and we also identified two novel mutations, R1941H and T2356I, in the coding sequence. These data suggest that parkinsonism caused by mutations in LRRK2 is likely to represent the commonest locus for autosomal dominant Parkinson's disease with a phenotype, pathology and in vivo imaging similar to idiopathic, late-onset Parkinson's disease.</abstract>
<qualityIndicators>
<score>8.5</score>
<pdfVersion>1.4</pdfVersion>
<pdfPageSize>612.288 x 790.87 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>12</keywordCount>
<abstractCharCount>1823</abstractCharCount>
<pdfWordCount>6302</pdfWordCount>
<pdfCharCount>40425</pdfCharCount>
<pdfPageCount>11</pdfPageCount>
<abstractWordCount>267</abstractWordCount>
</qualityIndicators>
<title>Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data</title>
<genre>
<json:string>research-article</json:string>
</genre>
<host>
<volume>128</volume>
<pages>
<last>2796</last>
<first>2786</first>
</pages>
<issn>
<json:string>0006-8950</json:string>
</issn>
<issue>12</issue>
<genre></genre>
<language>
<json:string>unknown</json:string>
</language>
<eissn>
<json:string>1460-2156</json:string>
</eissn>
<title>Brain</title>
</host>
<categories>
<wos>
<json:string>CLINICAL NEUROLOGY</json:string>
<json:string>NEUROSCIENCES</json:string>
</wos>
</categories>
<publicationDate>2005</publicationDate>
<copyrightDate>2005</copyrightDate>
<doi>
<json:string>10.1093/brain/awh667</json:string>
</doi>
<id>F12E94D16215631DFA9811475DAA34935074D886</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/F12E94D16215631DFA9811475DAA34935074D886/fulltext/pdf</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/F12E94D16215631DFA9811475DAA34935074D886/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/F12E94D16215631DFA9811475DAA34935074D886/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Oxford University Press</publisher>
<availability>
<p>OUP</p>
</availability>
<date>2005-11-04</date>
</publicationStmt>
<notesStmt>
<note>Correspondence to: Professor Nicholas W. Wood, Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London WC1N 3BG, UK E-mail: n.wood@ion.ucl.ac.uk</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data</title>
<author>
<persName>
<forename type="first">Naheed L.</forename>
<surname>Khan</surname>
</persName>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Shushant</forename>
<surname>Jain</surname>
</persName>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">John M.</forename>
<surname>Lynch</surname>
</persName>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Nicola</forename>
<surname>Pavese</surname>
</persName>
<affiliation>MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Patrick</forename>
<surname>Abou-Sleiman</surname>
</persName>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Janice L.</forename>
<surname>Holton</surname>
</persName>
<affiliation>Queen Square Brain Bank, Institute of Neurology,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Daniel G.</forename>
<surname>Healy</surname>
</persName>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">William P.</forename>
<surname>Gilks</surname>
</persName>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Mary G.</forename>
<surname>Sweeney</surname>
</persName>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Milan</forename>
<surname>Ganguly</surname>
</persName>
<affiliation>Queen Square Brain Bank, Institute of Neurology,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Vaneesha</forename>
<surname>Gibbons</surname>
</persName>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Sonia</forename>
<surname>Gandhi</surname>
</persName>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Jenny</forename>
<surname>Vaughan</surname>
</persName>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Louise H.</forename>
<surname>Eunson</surname>
</persName>
<affiliation>Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Regina</forename>
<surname>Katzenschlager</surname>
</persName>
<affiliation>Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Juliet</forename>
<surname>Gayton</surname>
</persName>
<affiliation>Exeter University, Exeter,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Graham</forename>
<surname>Lennox</surname>
</persName>
<affiliation>Department of Neurology, Addenbrooke's Hospital, Hills Road, Cambridge,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Tamas</forename>
<surname>Revesz</surname>
</persName>
<affiliation>Queen Square Brain Bank, Institute of Neurology,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">David</forename>
<surname>Nicholl</surname>
</persName>
<affiliation>Department of Neurology, Queen Elizabeth Hospital, Birmingham, UK and</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Kailash P.</forename>
<surname>Bhatia</surname>
</persName>
<affiliation>Sobell Department of Motor Neuroscience and Movement Disorders,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Niall</forename>
<surname>Quinn</surname>
</persName>
<affiliation>Sobell Department of Motor Neuroscience and Movement Disorders,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">David</forename>
<surname>Brooks</surname>
</persName>
<affiliation>MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Andrew J.</forename>
<surname>Lees</surname>
</persName>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Mary B.</forename>
<surname>Davis</surname>
</persName>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Paola</forename>
<surname>Piccini</surname>
</persName>
<affiliation>MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Andrew B.</forename>
<surname>Singleton</surname>
</persName>
<affiliation>Laboratory of Neurogenetics, National Institute of Aging, National Institutes of Health, Bethesda, MD, USA</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
<author>
<persName>
<forename type="first">Nicholas W.</forename>
<surname>Wood</surname>
</persName>
<affiliation>Sobell Department of Motor Neuroscience and Movement Disorders,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Brain</title>
<title level="j" type="abbrev">Brain</title>
<idno type="pISSN">0006-8950</idno>
<idno type="eISSN">1460-2156</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date type="published" when="2005-12"></date>
<biblScope unit="volume">128</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="2786">2786</biblScope>
<biblScope unit="page" to="2796">2796</biblScope>
</imprint>
</monogr>
<idno type="istex">F12E94D16215631DFA9811475DAA34935074D886</idno>
<idno type="DOI">10.1093/brain/awh667</idno>
<idno type="local">awh667</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2005-11-04</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>We have established that the frequency of LRRK2 mutations in a series of 118 cases of familial Parkinson's disease is 5.1%. In the largest family with autosomal dominant, late-onset Parkinson's disease where affected subjects share a Y1699C missense mutation we provide a detailed clinical, pathological and imaging report. The phenotype in this large British kindred included asymmetrical, levodopa-responsive parkinsonism where unilateral leg tremor at onset and foot dystonia were prominent features. There was no significant abnormality of cognition but there was prominent behavioural disorder. We observed a lower age of onset in successive generations. Histopathology in one patient showed substantia nigra cell loss and Lewy body formation, with small numbers of cortical Lewy bodies. 18F-dopa positron emission tomography (PET) in another patient showed a pattern of nigrostriatal dysfunction typical of idiopathic Parkinson's disease. 18F-dopa-PET scans in unaffected family members prior to identifying the disease locus did not detect subclinical nigrostriatal dysfunction. Olfaction was assessed in affected subjects and Lewy bodies were identified in the olfactory bulb as well as cortex and brainstem of one deceased patient. In order to assess the role of mutations in this gene in other familial cases we undertook a mutation screen of all 51 exons of LRRK2 in 117 other smaller British kindreds with familial Parkinson's disease. The commonest mutation was G2019S and we also identified two novel mutations, R1941H and T2356I, in the coding sequence. These data suggest that parkinsonism caused by mutations in LRRK2 is likely to represent the commonest locus for autosomal dominant Parkinson's disease with a phenotype, pathology and in vivo imaging similar to idiopathic, late-onset Parkinson's disease.</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>KWD</head>
<item>
<term>LRRK2</term>
</item>
<item>
<term>dardarin</term>
</item>
<item>
<term>Lewy bodies</term>
</item>
</list>
</keywords>
</textClass>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>ABR</head>
<item>
<term>ARSAC = Administration of Radioactive Substances Advisory Committee</term>
</item>
<item>
<term>cM = centimorgan</term>
</item>
<item>
<term>F-dopa PET = 18F-dopa positron emission tomography</term>
</item>
<item>
<term>LRRK2 = leucine-rich, repeat kinase 2</term>
</item>
<item>
<term>LOD = logarithm of the odds</term>
</item>
<item>
<term>NHNN = National Hospital for Neurology and Neurosurgery</term>
</item>
<item>
<term>NFTs = neurofibrillary tangles</term>
</item>
<item>
<term>UPSIT = University of Pennsylvania Smell Identification Test</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2005-11-04">Created</change>
<change when="2005-12">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/F12E94D16215631DFA9811475DAA34935074D886/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="corpus oup" wicri:toSee="no header">
<istex:xmlDeclaration>version="1.0" encoding="US-ASCII"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" URI="journalpublishing.dtd" name="istex:docType"></istex:docType>
<istex:document>
<article xml:lang="en" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="hwp">brain</journal-id>
<journal-id journal-id-type="nlm-ta">Brain</journal-id>
<journal-id journal-id-type="publisher-id">brainj</journal-id>
<journal-title>Brain</journal-title>
<abbrev-journal-title abbrev-type="publisher">Brain</abbrev-journal-title>
<issn pub-type="ppub">0006-8950</issn>
<issn pub-type="epub">1460-2156</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="other">awh667</article-id>
<article-id pub-id-type="doi">10.1093/brain/awh667</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mutations in the gene
<italic>LRRK2</italic>
encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Khan</surname>
<given-names>Naheed L.</given-names>
</name>
<xref rid="AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jain</surname>
<given-names>Shushant</given-names>
</name>
<xref rid="AFF1">1</xref>
<xref rid="AFF4">4</xref>
<xref rid="AFF9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lynch</surname>
<given-names>John M.</given-names>
</name>
<xref rid="AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pavese</surname>
<given-names>Nicola</given-names>
</name>
<xref rid="AFF5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abou-Sleiman</surname>
<given-names>Patrick</given-names>
</name>
<xref rid="AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Holton</surname>
<given-names>Janice L.</given-names>
</name>
<xref rid="AFF3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Healy</surname>
<given-names>Daniel G.</given-names>
</name>
<xref rid="AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gilks</surname>
<given-names>William P.</given-names>
</name>
<xref rid="AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sweeney</surname>
<given-names>Mary G.</given-names>
</name>
<xref rid="AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ganguly</surname>
<given-names>Milan</given-names>
</name>
<xref rid="AFF3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gibbons</surname>
<given-names>Vaneesha</given-names>
</name>
<xref rid="AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gandhi</surname>
<given-names>Sonia</given-names>
</name>
<xref rid="AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vaughan</surname>
<given-names>Jenny</given-names>
</name>
<xref rid="AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eunson</surname>
<given-names>Louise H.</given-names>
</name>
<xref rid="AFF4">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Katzenschlager</surname>
<given-names>Regina</given-names>
</name>
<xref rid="AFF4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gayton</surname>
<given-names>Juliet</given-names>
</name>
<xref rid="AFF6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lennox</surname>
<given-names>Graham</given-names>
</name>
<xref rid="AFF7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Revesz</surname>
<given-names>Tamas</given-names>
</name>
<xref rid="AFF3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nicholl</surname>
<given-names>David</given-names>
</name>
<xref rid="AFF8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bhatia</surname>
<given-names>Kailash P.</given-names>
</name>
<xref rid="AFF2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Quinn</surname>
<given-names>Niall</given-names>
</name>
<xref rid="AFF2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brooks</surname>
<given-names>David</given-names>
</name>
<xref rid="AFF5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lees</surname>
<given-names>Andrew J.</given-names>
</name>
<xref rid="AFF1">1</xref>
<xref rid="AFF4">4</xref>
<xref rid="AFF9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Davis</surname>
<given-names>Mary B.</given-names>
</name>
<xref rid="AFF1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Piccini</surname>
<given-names>Paola</given-names>
</name>
<xref rid="AFF5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Singleton</surname>
<given-names>Andrew B.</given-names>
</name>
<xref rid="AFF9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wood</surname>
<given-names>Nicholas W.</given-names>
</name>
<xref rid="AFF2">1</xref>
</contrib>
<aff>
<target target-type="aff" id="AFF1"></target>
<label>1</label>
Department of Molecular Neuroscience,
<target target-type="aff" id="AFF2"></target>
<label>2</label>
Sobell Department of Motor Neuroscience and Movement Disorders,
<target target-type="aff" id="AFF3"></target>
<label>3</label>
Queen Square Brain Bank, Institute of Neurology,
<target target-type="aff" id="AFF4"></target>
<label>4</label>
Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School,
<target target-type="aff" id="AFF5"></target>
<label>5</label>
MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,
<target target-type="aff" id="AFF6"></target>
<label>6</label>
Exeter University, Exeter,
<target target-type="aff" id="AFF7"></target>
<label>7</label>
Department of Neurology, Addenbrooke's Hospital, Hills Road, Cambridge,
<target target-type="aff" id="AFF8"></target>
<label>8</label>
Department of Neurology, Queen Elizabeth Hospital, Birmingham, UK and
<target target-type="aff" id="AFF9"></target>
<label>9</label>
Laboratory of Neurogenetics, National Institute of Aging, National Institutes of Health, Bethesda, MD, USA</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence to: Professor Nicholas W. Wood, Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London WC1N 3BG, UK E-mail:
<ext-link xlink:href="n.wood@ion.ucl.ac.uk" ext-link-type="email">n.wood@ion.ucl.ac.uk</ext-link>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>December</month>
<year>2005</year>
</pub-date>
<pub-date pub-type="epub">
<day>4</day>
<month>11</month>
<year>2005</year>
</pub-date>
<volume>128</volume>
<issue>12</issue>
<fpage>2786</fpage>
<lpage>2796</lpage>
<history>
<date date-type="accepted">
<day>27</day>
<month>9</month>
<year>2005</year>
</date>
<date date-type="received">
<day>5</day>
<month>9</month>
<year>2004</year>
</date>
<date date-type="rev-recd">
<day>26</day>
<month>9</month>
<year>2005</year>
</date>
</history>
<copyright-statement>© The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org</copyright-statement>
<copyright-year>2005</copyright-year>
<abstract xml:lang="en">
<p>We have established that the frequency of
<italic>LRRK2</italic>
mutations in a series of 118 cases of familial Parkinson's disease is 5.1%. In the largest family with autosomal dominant, late-onset Parkinson's disease where affected subjects share a Y1699C missense mutation we provide a detailed clinical, pathological and imaging report. The phenotype in this large British kindred included asymmetrical, levodopa-responsive parkinsonism where unilateral leg tremor at onset and foot dystonia were prominent features. There was no significant abnormality of cognition but there was prominent behavioural disorder. We observed a lower age of onset in successive generations. Histopathology in one patient showed substantia nigra cell loss and Lewy body formation, with small numbers of cortical Lewy bodies.
<sup>18</sup>
F-dopa positron emission tomography (PET) in another patient showed a pattern of nigrostriatal dysfunction typical of idiopathic Parkinson's disease.
<sup>18</sup>
F-dopa-PET scans in unaffected family members prior to identifying the disease locus did not detect subclinical nigrostriatal dysfunction. Olfaction was assessed in affected subjects and Lewy bodies were identified in the olfactory bulb as well as cortex and brainstem of one deceased patient. In order to assess the role of mutations in this gene in other familial cases we undertook a mutation screen of all 51 exons of
<italic>LRRK2</italic>
in 117 other smaller British kindreds with familial Parkinson's disease. The commonest mutation was G2019S and we also identified two novel mutations, R1941H and T2356I, in the coding sequence. These data suggest that parkinsonism caused by mutations in
<italic>LRRK2</italic>
is likely to represent the commonest locus for autosomal dominant Parkinson's disease with a phenotype, pathology and
<italic>in vivo</italic>
imaging similar to idiopathic, late-onset Parkinson's disease.</p>
</abstract>
<kwd-group kwd-group-type="KWD" xml:lang="en">
<kwd>LRRK2</kwd>
<kwd>dardarin</kwd>
<kwd>Lewy bodies</kwd>
</kwd-group>
<kwd-group kwd-group-type="ABR" xml:lang="en">
<kwd>ARSAC = Administration of Radioactive Substances Advisory Committee</kwd>
<kwd>cM = centimorgan</kwd>
<kwd>F-dopa PET =
<sup>18</sup>
F-dopa positron emission tomography</kwd>
<kwd>LRRK2 = leucine-rich, repeat kinase 2</kwd>
<kwd>LOD = logarithm of the odds</kwd>
<kwd>NHNN = National Hospital for Neurology and Neurosurgery</kwd>
<kwd>NFTs = neurofibrillary tangles</kwd>
<kwd>UPSIT = University of Pennsylvania Smell Identification Test</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>hwp-legacy-fpage</meta-name>
<meta-value>2786</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>December 2005</meta-value>
</custom-meta>
<custom-meta>
<meta-name>hwp-legacy-dochead</meta-name>
<meta-value>Original Article</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
</article>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data</title>
</titleInfo>
<titleInfo type="alternative" lang="en" contentType="CDATA">
<title>Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data</title>
</titleInfo>
<name type="personal">
<namePart type="given">Naheed L.</namePart>
<namePart type="family">Khan</namePart>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Shushant</namePart>
<namePart type="family">Jain</namePart>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">John M.</namePart>
<namePart type="family">Lynch</namePart>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Nicola</namePart>
<namePart type="family">Pavese</namePart>
<affiliation>MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Patrick</namePart>
<namePart type="family">Abou-Sleiman</namePart>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Janice L.</namePart>
<namePart type="family">Holton</namePart>
<affiliation>Queen Square Brain Bank, Institute of Neurology,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Daniel G.</namePart>
<namePart type="family">Healy</namePart>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">William P.</namePart>
<namePart type="family">Gilks</namePart>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Mary G.</namePart>
<namePart type="family">Sweeney</namePart>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Milan</namePart>
<namePart type="family">Ganguly</namePart>
<affiliation>Queen Square Brain Bank, Institute of Neurology,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Vaneesha</namePart>
<namePart type="family">Gibbons</namePart>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Sonia</namePart>
<namePart type="family">Gandhi</namePart>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Jenny</namePart>
<namePart type="family">Vaughan</namePart>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Louise H.</namePart>
<namePart type="family">Eunson</namePart>
<affiliation>Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Regina</namePart>
<namePart type="family">Katzenschlager</namePart>
<affiliation>Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Juliet</namePart>
<namePart type="family">Gayton</namePart>
<affiliation>Exeter University, Exeter,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Graham</namePart>
<namePart type="family">Lennox</namePart>
<affiliation>Department of Neurology, Addenbrooke's Hospital, Hills Road, Cambridge,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Tamas</namePart>
<namePart type="family">Revesz</namePart>
<affiliation>Queen Square Brain Bank, Institute of Neurology,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">David</namePart>
<namePart type="family">Nicholl</namePart>
<affiliation>Department of Neurology, Queen Elizabeth Hospital, Birmingham, UK and</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Kailash P.</namePart>
<namePart type="family">Bhatia</namePart>
<affiliation>Sobell Department of Motor Neuroscience and Movement Disorders,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Niall</namePart>
<namePart type="family">Quinn</namePart>
<affiliation>Sobell Department of Motor Neuroscience and Movement Disorders,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">David</namePart>
<namePart type="family">Brooks</namePart>
<affiliation>MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Andrew J.</namePart>
<namePart type="family">Lees</namePart>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Mary B.</namePart>
<namePart type="family">Davis</namePart>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Paola</namePart>
<namePart type="family">Piccini</namePart>
<affiliation>MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Andrew B.</namePart>
<namePart type="family">Singleton</namePart>
<affiliation>Laboratory of Neurogenetics, National Institute of Aging, National Institutes of Health, Bethesda, MD, USA</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Nicholas W.</namePart>
<namePart type="family">Wood</namePart>
<affiliation>Sobell Department of Motor Neuroscience and Movement Disorders,</affiliation>
<affiliation>Department of Molecular Neuroscience,</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="research-article"></genre>
<originInfo>
<publisher>Oxford University Press</publisher>
<dateIssued encoding="w3cdtf">2005-12</dateIssued>
<dateCreated encoding="w3cdtf">2005-11-04</dateCreated>
<copyrightDate encoding="w3cdtf">2005</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
</physicalDescription>
<abstract lang="en">We have established that the frequency of LRRK2 mutations in a series of 118 cases of familial Parkinson's disease is 5.1%. In the largest family with autosomal dominant, late-onset Parkinson's disease where affected subjects share a Y1699C missense mutation we provide a detailed clinical, pathological and imaging report. The phenotype in this large British kindred included asymmetrical, levodopa-responsive parkinsonism where unilateral leg tremor at onset and foot dystonia were prominent features. There was no significant abnormality of cognition but there was prominent behavioural disorder. We observed a lower age of onset in successive generations. Histopathology in one patient showed substantia nigra cell loss and Lewy body formation, with small numbers of cortical Lewy bodies. 18F-dopa positron emission tomography (PET) in another patient showed a pattern of nigrostriatal dysfunction typical of idiopathic Parkinson's disease. 18F-dopa-PET scans in unaffected family members prior to identifying the disease locus did not detect subclinical nigrostriatal dysfunction. Olfaction was assessed in affected subjects and Lewy bodies were identified in the olfactory bulb as well as cortex and brainstem of one deceased patient. In order to assess the role of mutations in this gene in other familial cases we undertook a mutation screen of all 51 exons of LRRK2 in 117 other smaller British kindreds with familial Parkinson's disease. The commonest mutation was G2019S and we also identified two novel mutations, R1941H and T2356I, in the coding sequence. These data suggest that parkinsonism caused by mutations in LRRK2 is likely to represent the commonest locus for autosomal dominant Parkinson's disease with a phenotype, pathology and in vivo imaging similar to idiopathic, late-onset Parkinson's disease.</abstract>
<note type="author-notes">Correspondence to: Professor Nicholas W. Wood, Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London WC1N 3BG, UK E-mail: n.wood@ion.ucl.ac.uk</note>
<subject lang="en">
<genre>KWD</genre>
<topic>LRRK2</topic>
<topic>dardarin</topic>
<topic>Lewy bodies</topic>
</subject>
<subject lang="en">
<genre>ABR</genre>
<topic>ARSAC = Administration of Radioactive Substances Advisory Committee</topic>
<topic>cM = centimorgan</topic>
<topic>F-dopa PET = 18F-dopa positron emission tomography</topic>
<topic>LRRK2 = leucine-rich, repeat kinase 2</topic>
<topic>LOD = logarithm of the odds</topic>
<topic>NHNN = National Hospital for Neurology and Neurosurgery</topic>
<topic>NFTs = neurofibrillary tangles</topic>
<topic>UPSIT = University of Pennsylvania Smell Identification Test</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Brain</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>Brain</title>
</titleInfo>
<genre type="Journal">journal</genre>
<identifier type="ISSN">0006-8950</identifier>
<identifier type="eISSN">1460-2156</identifier>
<identifier type="PublisherID">brainj</identifier>
<identifier type="PublisherID-hwp">brain</identifier>
<identifier type="PublisherID-nlm-ta">Brain</identifier>
<part>
<date>2005</date>
<detail type="volume">
<caption>vol.</caption>
<number>128</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>12</number>
</detail>
<extent unit="pages">
<start>2786</start>
<end>2796</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">F12E94D16215631DFA9811475DAA34935074D886</identifier>
<identifier type="DOI">10.1093/brain/awh667</identifier>
<identifier type="local">awh667</identifier>
<accessCondition type="use and reproduction" contentType="copyright">© The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org</accessCondition>
<recordInfo>
<recordContentSource>OUP</recordContentSource>
</recordInfo>
</mods>
</metadata>
<covers>
<json:item>
<original>true</original>
<mimetype>image/tiff</mimetype>
<extension>tiff</extension>
<uri>https://api.istex.fr/document/F12E94D16215631DFA9811475DAA34935074D886/covers/tiff</uri>
</json:item>
<json:item>
<original>true</original>
<mimetype>text/html</mimetype>
<extension>html</extension>
<uri>https://api.istex.fr/document/F12E94D16215631DFA9811475DAA34935074D886/covers/html</uri>
</json:item>
</covers>
<annexes>
<json:item>
<original>true</original>
<mimetype>image/jpeg</mimetype>
<extension>jpeg</extension>
<uri>https://api.istex.fr/document/F12E94D16215631DFA9811475DAA34935074D886/annexes/jpeg</uri>
</json:item>
<json:item>
<original>true</original>
<mimetype>image/gif</mimetype>
<extension>gif</extension>
<uri>https://api.istex.fr/document/F12E94D16215631DFA9811475DAA34935074D886/annexes/gif</uri>
</json:item>
</annexes>
<enrichments>
<istex:catWosTEI uri="https://api.istex.fr/document/F12E94D16215631DFA9811475DAA34935074D886/enrichments/catWos">
<teiHeader>
<profileDesc>
<textClass>
<classCode scheme="WOS">CLINICAL NEUROLOGY</classCode>
<classCode scheme="WOS">NEUROSCIENCES</classCode>
</textClass>
</profileDesc>
</teiHeader>
</istex:catWosTEI>
</enrichments>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002836 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 002836 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:F12E94D16215631DFA9811475DAA34935074D886
   |texte=   Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024